Nomura Holdings’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Sell
20,000
-30,000
-60% -$3.63M ﹤0.01% 1108
2026
Q1
$8.18M Buy
50,000
+4,000
+9% +$615K 0.02% 477
2025
Q4
$8.01M Buy
+46,000
New +$8.39M 0.01% 616
2025
Q3
Sell
-22,000
Closed -$2.21M 1969
2025
Q2
$2.21M Buy
+22,000
New +$1.68M ﹤0.01% 815
2024
Q3
Sell
-52,600
Closed -$3.52M 1755
2024
Q2
$3.52M Buy
+52,600
New +$2.04M 0.01% 753

Other funds holding INSM

Nomura Holdings's INSM Position: Q2 2026 in Review

Nomura Holdings increased its Insmed (INSM) stake by 89% in Q2 2026, buying an estimated $2.05M and bringing the position to 36,000 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #871.

Nomura Holdings first reported a position in INSM in Q1 2014 and has held it in 14 quarters since. The position peaked at $5.31M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Nomura Holdings held 36,000 shares of Insmed worth $3.84M as of Q2 2026.
  • Nomura Holdings bought 16,955 Insmed shares in Q2 2026, an estimated $2.05M.
  • Insmed made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #871 holding.
  • Nomura Holdings first reported a position in Insmed in Q1 2014 and has held it in 14 quarters since.
  • Nomura Holdings's Insmed position peaked at $5.31M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.